Friday, September 24, 2021
wellness India Expo
Home Tags Oncology

Tag: Oncology

CORE Diagnostics gets accredited by College of American Pathologists

Accreditation by CAP is widely regarded internationally in the diagnostics industry that signifies the highest quality standards of tests across regions...........................

Lupin achieves key milestones for its potential therapy to treat difficult...

Lupin’s proprietary MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancer...........................

“Sukino is India’s first comprehensive continuum care provider”

In an exclusive interview with BioVoice, Rajinish Menon, Founder and Chief Executive Officer, Sukino Healthcare, shared the company's foundational story, his views on the concept of Continuum Care in India, revenue model, growth drivers, and future outlook...............

Here’s how AI can transform Cancer care in India

For an annual incidence of more than 1 million new Cancer diagnoses every year, India has barely 2,000 pathologists experienced in oncology, writes Dr Anil Heroor, Head-Surgical Oncology, Fortis Hospital, Mulund......................  

Top Asian oncologists bat for access to cancer services, say it...

COVID-19 has had a significant impact on cancer services negatively across Asia and there has been a drop in the number of patients accessing cancer services in the region....................

Awareness is the key to beat breast cancer: RGCIRC Experts

The Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is running a campaign 'Big or Small - Save Them All', through an appeal to the women that breast cancer is curable if detected early......................

“Plasma therapy needs to be explored, may turn out to be...

Dr Shekhar Kirani, Spokesperson, ACT Grants and Dr Vishal Rao  Regional Director, Head Neck Surgical Oncology and Robotic Surgery, HCG share their views on the initiative to build a plasma bank and a plasma council besides various other aspects related to plasma therapy....................

Cipla expands partnership with Roche Pharma to improve access to key...

Cipla signs a distribution agreement with Roche Products (India) Pvt. Ltd. to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India.........................

CSIR’s anti-pancreatic cancer drug IIIM-290 gets approval for clinical trial

Approval from the New Drugs Division of Central Drugs Standard Control Organization (CDSCO) will pave way for CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu for conducting the clinical trial of this important drug candidate IIIM-290 in pancreatic cancer patients....................

Oncocyte ties up with CORE Diagnostics to market its cancer testing...

In the United States, DetermaRx™ has rapidly gained traction, expanding to 18 sites in the first three months since commercial launch. The company is now is expanding commercial availability of DetermaRx™ to India, the Middle East and Africa..................